Physician profile
Mohsin Hamid
NPI 1134501539
$10,145.81
in general payments reported to CMS, 2019-2025
23 companies · $1,261 in 2025
The $1,261 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2022: $297 · 2023: $1,266 · 2024: $7,200 · 2025: $1,261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,560 · Education: $2,664 · Travel and Lodging: $2,502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,560.49 |
| Education | $2,663.98 |
| Travel and Lodging | $2,502.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,190.48 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $1,300.71 | 2022-2025 | Tezspire, Airsupra, Fasenra |
| Actelion Pharmaceuticals US, INC. | $912.13 | 2022-2025 | Uptravi, Opsumit, Opsynvi |
| Glaxosmithkline, LLC. | $791.90 | 2022-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Regeneron Healthcare Solutions, INC. | $576.91 | 2019-2024 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $317.54 | 2022-2025 | Ofev, Jascayd, Stiolto Respimat |
| Genzyme Corporation | $272.12 | 2024-2025 | |
| Amgen INC. | $201.83 | 2022-2025 | Tezspire |
| Abbvie INC. | $108.07 | 2022-2025 | |
| Insmed, INC. | $99.35 | 2023-2025 | Arikayce, Brinsupri |
| Sanofi-Aventis U.S. LLC | $78.99 | 2024 | |
| Harmony Biosciences LLC | $59.27 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $33.21 | 2023 | |
| Baxter Healthcare | $32.56 | 2023 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Philips North America LLC | $28.42 | 2022-2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $24.03 | 2023 | Yupelri |
| Pulmonx Corporation | $19.95 | 2023 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
| Inspire Medical Systems, INC. | $19.75 | 2025 | Inspire |
| United Therapeutics Corporation | $16.76 | 2025 | Tyvaso |
| Jazz Pharmaceuticals INC. | $15.96 | 2024 | |
| Grifols USA, LLC | $15.72 | 2024 | Prolastin-C Liquid |
| Noah Medical Corporation | $15.60 | 2024 | Galaxy |
| Ethicon INC. | $14.55 | 2024 | Monarch Platform |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohsin Hamid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.